A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer’s Disease

Numerous clinical trials of drug candidates for Alzheimer’s disease (AD) have failed, and computational drug repositioning approaches using omics data have been proposed as effective alternative approaches to the discovery of drug candidates. However, little multi-omics data is available for AD, due...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Soo Youn, Song, Min-Young, Kim, Dain, Park, Chaewon, Park, Da Kyeong, Kim, Dong Geun, Yoo, Jong Shin, Kim, Young Hye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000455/
https://www.ncbi.nlm.nih.gov/pubmed/32063857
http://dx.doi.org/10.3389/fphar.2019.01653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000455/
https://www.ncbi.nlm.nih.gov/pubmed/32063857
http://dx.doi.org/10.3389/fphar.2019.01653

Ejemplares similares